Christian Odendahl, chief economist at the Centre for European Reform, shared an article on vaccines being oversold as part of the pandemic exit strategy.
However, the article highlighted the urgent need for vaccination to continue alongside virus suppression efforts as regions with raging transmission served as a breeding ground for other resistant variants.
Leading science commentators such as Anjana Ahuja, writes that if logistics permitted, approximately 15 million people in the UK would receive their first dose of the coronavirus vaccine by February.
In addition, provided the second dose is administered in time, the vulnerable sections of the population would not require intensive care hospitalisations.
A model from the University of East Anglia suggests normalcy is far from achieved, even with the rollout of vaccines.
It is being suggested that imperfect vaccine efficacy, poor uptake of vaccines, and the birth of infectious variants could hinder attempts to achieve herd immunity.